

Mechanism of actionThe drug that regulates the balance of intestinal microflora. Due to the presence of an acid-resistant capsule, lactic acid bacteria do not collapse under the influence of gastric juice. When reaching the intestinal level of pH = 6.0-6.8 capsule dissolves. Bacteria actively colonize the small and large intestine. Acetic and lactic acids are produced, thereby inhibiting the growth and reproduction of pathogenic microorganisms. Bifidobacteria and enterococci are also involved in the synthesis and absorption of Vitamins, enzymatic cleavage of proteins, fats and complex carbohydrates (including in lactase deficiency in children). Bacterial strains with a predictable high level of antibiotic resistance are used. Currently, there are no pharmacokinetic models for the study in humans of complex biological substances consisting of components with different molecular weights. Indications and usage- for the normalization of intestinal microflora, as well as for the prevention and treatment of gastrointestinal disorders in children over 2 years old and adults. Prescribe adults and children from 2 years 2-3 capsules / day. If necessary, the daily dose may be increased to 4 capsules. Adverse reactionsWhen using the drug in recommended doses, side effects are not installed. ContraindicationsCurrently, no contraindications have been established. Pregnancy and breastfeedingThe question of the use of the drug Bifiform during pregnancy and lactation (breastfeeding) is decided individually depending on the clinical situation. OverdosageCurrently, no cases of overdose of the drug Bifiform have been reported. Drug InteractionsDrug interaction of the drug Bifiform is not described. The drug should be stored in a dry place inaccessible to children, in a tightly closed container at a temperature not exceeding 15 ° C. Shelf life - 2 years. |